Mind Medicine (MindMed) - 9 Year Stock Price History | MNMD

The latest closing stock price for Mind Medicine (MindMed) as of June 24, 2025 is 7.14.

  • An investor who bought $1,000 worth of Mind Medicine (MindMed) stock at the IPO in 2016 would have $-735 today, roughly -1 times their original investment - a -13.71% compound annual growth rate over 9 years.
  • The all-time high Mind Medicine (MindMed) stock closing price was 150.00 on March 17, 2017.
  • The Mind Medicine (MindMed) 52-week high stock price is 10.44, which is 46.2% above the current share price.
  • The Mind Medicine (MindMed) 52-week low stock price is 4.70, which is 34.2% below the current share price.
  • The average Mind Medicine (MindMed) stock price for the last 52 weeks is 6.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.

Mind Medicine (MindMed) - 9 Year Stock Price History | MNMD

  • An investor who bought $1,000 worth of Mind Medicine (MindMed) stock at the IPO in 2016 would have $-735 today, roughly -1 times their original investment - a -13.71% compound annual growth rate over 9 years.
  • The all-time high Mind Medicine (MindMed) stock closing price was 150.00 on March 17, 2017.
  • The Mind Medicine (MindMed) 52-week high stock price is 10.44, which is 46.2% above the current share price.
  • The Mind Medicine (MindMed) 52-week low stock price is 4.70, which is 34.2% below the current share price.
  • The average Mind Medicine (MindMed) stock price for the last 52 weeks is 6.90.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Related Stocks
Company NameMarket
Cap
AstraZeneca (AZN)$209.6B
Amgen (AMGN)$149.1B
Gilead Sciences (GILD)$130.2B
Vertex Pharmaceuticals (VRTX)$125.6B
Bristol Myers Squibb (BMY)$100.2B
CSL (CSLLY)$74.3B
GSK (GSK)$74.1B
Regeneron Pharmaceuticals (REGN)$61.6B
Argenex SE (ARGX)$36.2B
Alnylam Pharmaceuticals (ALNY)$30.5B
BioNTech SE (BNTX)$23.7B
BeiGene (ONC)$22.8B
Biogen (BIIB)$17.4B
Genmab (GMAB)$13.3B
Genmab (GNMSF)$13.3B
Insmed (INSM)$13.2B
BioMarin Pharmaceutical (BMRN)$11.3B
Illumina (ILMN)$11.3B
Incyte (INCY)$11.3B
Ascendis Pharma (ASND)$10.1B
Exelixis (EXEL)$10B
Swedish Orphan Biovitrum (BIOVF)$9.6B
Moderna (MRNA)$9.6B
QIAGEN (QGEN)$9B
Exact Sciences (EXAS)$7.7B
Bio-Techne Corp (TECH)$7.6B
Repligen (RGEN)$7.3B
Halozyme Therapeutics (HALO)$7.3B
Roivant Sciences (ROIV)$7.2B
Revolution Medicines (RVMD)$6.8B